Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
I spent much more of my life thinking about food than I realized
Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial
Moreover, the rising prevalence of obesity and type 2 diabetes (T2D) globally continues to significantly boost market demand, as GLP-1 agonists play an essential role in the treatment and management of these conditions
The weight loss from both medications comes from reduced appetite and slower stomach emptying, which leads to eating less without feeling deprived
Psychiatry 133 , 429435 (1978)
US$ 21.50
US$ 26.92
US$ 28.27
US$ 20.55
US$ 21.92
